http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015111831-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ede47b877b6df9c8d0c494cd66f45ae8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8ba5f2b7fd1ab8e77fbd07f236a4e32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f0ebd9dcbad97a7ac05614027677ef6 |
| publicationDate | 2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2015111831-A1 |
| titleOfInvention | Method for treating glioma using tarbp2 |
| abstract | A pharmaceutical composition and a method for treating glioma are provided. The pharmaceutical composition for preventing or treating glioma includes a Tar RNA binding protein 2 (Tarbp2) protein or gene encoding the same as an active component. The method for treating glioma includes administering to a subject in need thereof a pharmaceutically effective amount of aTar RNA binding protein 2 (Tarbp2) protein or gene encoding the same. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111333717-A |
| priorityDate | 2013-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.